Novartis To Launch Six New Drugs In China
This article was originally published in PharmAsia News
Executive Summary
Novartis says it plans to launch six new drugs in China this year in an effort to boost the nation's share of Novartis sales beyond the current 1 percent. As part of its plans in China, Novartis says it will increase its local staff by 20 percent this year, bucking the trend of most other multinational companies of reducing staff. The Novartis plan envisions increasing global sales by 5 percent this year and is counting on China to help achieve that goal. (Click here for more
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.